NeuroPace (NPCE) EBIT Growth (1y) (2021 - 2026)
Powered by 
Analysis
NeuroPace (NPCE) EBIT Growth (1y) (2021 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn | -17.50% |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn | 30.74% |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn | 22.08% |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn | 49.06% |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn | 43.83% |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn | 24.81% |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn | -95.55% |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn | 49.72% |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn | 16.18% |
| 10 | NeuroPace | 493.15 Mn | 441.45 Mn | 18.91 Mn | 37.20% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 37.20% |
| Mar 31, 2026 | -8.18% |
| Dec 31, 2025 | 51.63% |
| Sep 30, 2025 | 38.72% |
| Jun 30, 2025 | -31.44% |
| Mar 31, 2025 | 31.78% |
| Dec 31, 2024 | 27.68% |
| Sep 30, 2024 | 28.69% |
| Jun 30, 2024 | 20.68% |
| Mar 31, 2024 | 9.30% |
| Dec 31, 2023 | 48.77% |
| Sep 30, 2023 | 41.66% |
| Jun 30, 2023 | 28.43% |
| Mar 31, 2023 | 14.78% |
| Dec 31, 2022 | -9.36% |
| Sep 30, 2022 | -63.37% |
| Jun 30, 2022 | -138.31% |
| Mar 31, 2022 | -151.99% |
| Dec 31, 2021 | -202.42% |
| Sep 30, 2021 | -435.42% |